We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Guerbet

Offers products in medical imaging - diagnostic imaging, contrast media - contrast agents, MRI imaging, X Ray imaging... read more Featured Products: More products

Download Mobile App





Guerbet Showcases New Dose&Care and Other Digital Solutions with Diagnostic and Interventional Imaging Offerings

By MedImaging International staff writers
Posted on 04 Dec 2019
Print article
Illustration
Illustration
Guerbet LLC USA (Princeton, N.J., USA) highlighted both new and established products in contrast media, injectors, disposables and digital solutions at the 2019 annual meeting of the Radiological Society of North America (RSNA) in Chicago, USA. At RSNA 2019, visitors had a hands-on experience with cutting-edge technology, including artificial intelligence (AI), 3D printing and virtual reality. The event allowed visitors to dive into the latest research, talk to over 700 vendors about their innovative products and services, enhance their skills at over 400 educational courses, and join 50,000 attendees to meet the leaders shaping tomorrow.

Guerbet LLC USA is the US affiliate of Guerbet, a pioneer and global specialist in contrast media products and comprehensive solutions for medical imaging. Guerbet offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients.

At Guerbet LLC USA’s RSNA 2019 booth, an interactive Patient Pathway guided HCPs through an educational tour and live demonstration of the company’s product offerings across the patient experience, beginning with initial examination and diagnosis, moving to treatment with image-guided intervention, and ending with follow-up monitoring technologies. The Patient Pathway offered live demonstrations of Dose&Care, a state-of-the-art digital solution to monitor patients' exposure to X-rays; Contrast&Care, a next-level contrast media injection management solution enabling imaging centers to collect, archive, examine and share data directly with Guerbet's injectors to help radiologists with patient care; IBM Watson Imaging Patient Synopsis, a radiologist-trained AI tool that aims to extract relevant patient information and summarizes into a tailored and specific dashboard to help inform diagnostic decisions. Guerbet LLC USA’s booth at RSNA 2019 also featured information on UNIK, an innovative solution tailored for HCPs and decision-makers, to add value at each step of the healthcare journey by interconnecting the company’s comprehensive portfolio of contrast media, injection solutions, digital solutions and technical support.

Related Links:
Guerbet LLC USA


Print article
Radcal
CIRS

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.